WST · NYSE
West Pharmaceutical Services (WST) Stock Price & Fundamentals
West Pharmaceutical Services (WST) closed at $320.91 on Oct 9, 2026, down 0.84% from the previous close of $323.64.
Share price, past year
1Y +16.53%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $320.91 |
| Sep 30, 2026 | $327.19 |
| Aug 31, 2026 | $332.40 |
| Jul 31, 2026 | $320.04 |
| Jun 30, 2026 | $310.22 |
| May 29, 2026 | $305.53 |
| Apr 30, 2026 | $289.16 |
| Mar 31, 2026 | $289.14 |
| Feb 27, 2026 | $274.15 |
| Jan 30, 2026 | $265.53 |
| Dec 31, 2025 | $262.96 |
| Nov 28, 2025 | $266.22 |
| Oct 31, 2025 | $293.58 |
Key statistics
- Market cap
- $22.59B
- P/E (TTM)
- 41.1
- EPS (TTM)
- $7.81
- Revenue (TTM)
- $3.33B
- Net income (TTM)
- $564.90M
- Shares outstanding
- 70.4M
- Dividend yield
- 0.27%
- 52-week range
- $256.81 – $335.12
West Pharmaceutical Services's market cap is $22.59B, based on a share price of $320.91 and 70.4M shares outstanding as of Jun 30, 2026.
Financials
West Pharmaceutical Services reported revenue of $3.07B for fiscal 2025, up 6.25% from fiscal 2024.
West Pharmaceutical Services earned net income of $493.70M in fiscal 2025, a net margin of 16.1%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $3.07B | +6.3% | $493.70M | 16.1% | $6.79 | $468.90M |
| FY2024ended Dec 31, 2024 | $2.89B | −1.9% | $492.70M | 17.0% | $6.69 | $276.40M |
| FY2023ended Dec 31, 2023 | $2.95B | +2.2% | $593.40M | 20.1% | $7.88 | $414.50M |
| FY2022ended Dec 31, 2022 | $2.89B | +2.0% | $585.90M | 20.3% | $7.73 | $439.40M |
| FY2021ended Dec 31, 2021 | $2.83B | +31.9% | $661.80M | 23.4% | $8.67 | $330.60M |
| FY2020ended Dec 31, 2020 | $2.15B | +16.7% | $346.20M | 16.1% | $4.57 | $298.10M |
| FY2019ended Dec 31, 2019 | $1.84B | +7.1% | $241.70M | 13.1% | $3.21 | $240.80M |
| FY2018ended Dec 31, 2018 | $1.72B | +7.4% | $206.90M | 12.1% | $2.74 | $183.90M |
| FY2017ended Dec 31, 2017 | $1.60B | +6.0% | — | — | $1.99 | $132.50M |
| FY2016ended Dec 31, 2016 | $1.51B | — | — | — | $1.91 | $49.20M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $872.30M | $154.00M | $2.15 |
| Q1 FY2026ended Mar 31, 2026 | $844.90M | $138.80M | $1.92 |
| Q4 FY2025ended Dec 31, 2025 | $805.00M | $132.10M | $1.82 |
| Q3 FY2025ended Sep 30, 2025 | $804.60M | $140.00M | $1.92 |
| Q2 FY2025ended Jun 30, 2025 | $766.50M | $131.80M | $1.82 |
| Q1 FY2025ended Mar 31, 2025 | $698.00M | $89.80M | $1.23 |
| Q4 FY2024ended Dec 31, 2024 | $748.80M | $130.10M | $1.78 |
| Q3 FY2024ended Sep 30, 2024 | $746.90M | $136.00M | $1.85 |
Company profile
- Name
- West Pharmaceutical Services, Inc.
- Ticker
- WST
- Exchange
- NYSE
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 530 Herman O. West Drive, Exton, PA 19341
- Incorporated in
- PA
- Fiscal year ends
- December
- SEC CIK
- 0000105770
Recent SEC filings
- Jul 23, 2026
- Jul 23, 2026
- Jul 14, 2026
- Jun 1, 2026
- May 11, 2026
- May 5, 2026
- Apr 23, 2026
- Apr 23, 2026
Frequently asked questions
What is West Pharmaceutical Services's stock price?
West Pharmaceutical Services (WST) closed at $320.91 on Oct 9, 2026, down 0.84% from the previous close of $323.64.
What is West Pharmaceutical Services's market cap?
West Pharmaceutical Services's market cap is $22.59B, based on a share price of $320.91 and 70.4M shares outstanding as of Jun 30, 2026.
How much revenue does West Pharmaceutical Services make?
West Pharmaceutical Services reported revenue of $3.07B for fiscal 2025, up 6.25% from fiscal 2024.
What is WST's P/E ratio?
West Pharmaceutical Services's price-to-earnings ratio is 41.1, based on trailing twelve-month diluted EPS of $7.81.
Does West Pharmaceutical Services pay a dividend?
Yes. West Pharmaceutical Services declared $0.87 per share in dividends over the last four quarters, a yield of 0.27%.
Sources and methodology
Fundamentals come from West Pharmaceutical Services, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures